1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Oct 17, 2024
Read More Apparatus Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer! Nov 22, 2024
Read More Medical New Developments In Gastric Cancer Research: Keytruda In Combination With Chemotherapy Significantly Improves Survival In Patients With Advanced Disease! Nov 09, 2024
